China
· Delayed Price · Currency is CNY Chongqing Zhifei Biological Products Statistics
Total Valuation
Chongqing Zhifei Biological Products has a market cap or net worth of CNY 59.29 billion. The enterprise value is 65.11 billion.
| Market Cap | 59.29B |
| Enterprise Value | 65.11B |
Important Dates
The next estimated earnings date is Tuesday, April 22, 2025.
| Earnings Date | Apr 22, 2025 |
| Ex-Dividend Date | Dec 25, 2024 |
Share Statistics
Chongqing Zhifei Biological Products has 2.39 billion shares outstanding. The number of shares has decreased by -0.12% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 2.39B |
| Shares Change (YoY) | -0.12% |
| Shares Change (QoQ) | -0.24% |
| Owned by Insiders (%) | 59.06% |
| Owned by Institutions (%) | 14.19% |
| Float | 980.08M |
Valuation Ratios
The trailing PE ratio is 16.09 and the forward PE ratio is 13.75.
| PE Ratio | 16.09 |
| Forward PE | 13.75 |
| PS Ratio | 1.63 |
| PB Ratio | 1.89 |
| P/TBV Ratio | 1.91 |
| P/FCF Ratio | 25.44 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.02, with an EV/FCF ratio of 27.94.
| EV / Earnings | 17.64 |
| EV / Sales | 1.79 |
| EV / EBITDA | 15.02 |
| EV / EBIT | 16.23 |
| EV / FCF | 27.94 |
Financial Position
The company has a current ratio of 2.10, with a Debt / Equity ratio of 0.29.
| Current Ratio | 2.10 |
| Quick Ratio | 1.14 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 2.09 |
| Debt / FCF | 3.90 |
| Interest Coverage | 37.47 |
Financial Efficiency
Return on equity (ROE) is 12.02% and return on invested capital (ROIC) is 6.70%.
| Return on Equity (ROE) | 12.02% |
| Return on Assets (ROA) | 4.87% |
| Return on Capital (ROIC) | 6.70% |
| Revenue Per Employee | 5.57M |
| Profits Per Employee | 563,815 |
| Employee Count | 6,545 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 1.76 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -58.54% in the last 52 weeks. The beta is 0.92, so Chongqing Zhifei Biological Products's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -58.54% |
| 50-Day Moving Average | 29.13 |
| 200-Day Moving Average | 31.16 |
| Relative Strength Index (RSI) | 25.26 |
| Average Volume (20 Days) | 20,799,286 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Chongqing Zhifei Biological Products had revenue of CNY 36.43 billion and earned 3.69 billion in profits. Earnings per share was 1.54.
| Revenue | 36.43B |
| Gross Profit | 9.02B |
| Operating Income | 4.01B |
| Pretax Income | 4.20B |
| Net Income | 3.69B |
| EBITDA | 4.32B |
| EBIT | 4.01B |
| Earnings Per Share (EPS) | 1.54 |
Balance Sheet
The company has 3.26 billion in cash and 9.08 billion in debt, giving a net cash position of -5.82 billion or -2.43 per share.
| Cash & Cash Equivalents | 3.26B |
| Total Debt | 9.08B |
| Net Cash | -5.82B |
| Net Cash Per Share | -2.43 |
| Equity (Book Value) | 31.44B |
| Book Value Per Share | 13.13 |
| Working Capital | 23.81B |
Cash Flow
In the last 12 months, operating cash flow was 3.35 billion and capital expenditures -1.01 billion, giving a free cash flow of 2.33 billion.
| Operating Cash Flow | 3.35B |
| Capital Expenditures | -1.01B |
| Free Cash Flow | 2.33B |
| FCF Per Share | 0.97 |
Margins
Gross margin is 24.77%, with operating and profit margins of 11.01% and 10.13%.
| Gross Margin | 24.77% |
| Operating Margin | 11.01% |
| Pretax Margin | 11.53% |
| Profit Margin | 10.13% |
| EBITDA Margin | 11.87% |
| EBIT Margin | 11.01% |
| FCF Margin | 6.40% |
Dividends & Yields
This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 3.17%.
| Dividend Per Share | 0.80 |
| Dividend Yield | 3.17% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | 54.82% |
| Buyback Yield | 0.12% |
| Shareholder Yield | 3.29% |
| Earnings Yield | 6.22% |
| FCF Yield | 3.93% |
Stock Splits
The last stock split was on June 16, 2023. It was a forward split with a ratio of 1.5.
| Last Split Date | Jun 16, 2023 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
Chongqing Zhifei Biological Products has an Altman Z-Score of 4.98.
| Altman Z-Score | 4.98 |
| Piotroski F-Score | n/a |